A study elucidated that TGF-β1 could promote the expression of TSP-2 which in turn interacted with integrin αvβ3/CD36, and then activated MAPK signaling to drive the progression of pancreatic cancer [21]. The gene discussed is CD36; the disease is pancreatic neoplasm.